Annual SGA
$3.97 M
-$51.30 K-1.28%
December 1, 2023
Summary
- As of February 8, 2025, DRMA annual SGA is $3.97 million, with the most recent change of -$51.30 thousand (-1.28%) on December 1, 2023.
- During the last 3 years, DRMA annual SGA has risen by +$2.41 million (+153.81%).
- DRMA annual SGA is now -9.67% below its all-time high of $4.40 million, reached on December 31, 2021.
Performance
DRMA SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$824.30 K
-$50.30 K-5.75%
September 1, 2024
Summary
- As of February 8, 2025, DRMA quarterly SGA is $824.30 thousand, with the most recent change of -$50.30 thousand (-5.75%) on September 1, 2024.
- Over the past year, DRMA quarterly SGA has dropped by -$260.30 thousand (-24.00%).
- DRMA quarterly SGA is now -48.57% below its all-time high of $1.60 million, reached on March 1, 2024.
Performance
DRMA Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$231.79 M
-$11.27 M-5.11%
September 1, 2024
Summary
- As of February 8, 2025, DRMA TTM SGA is -$231.79 million, with the most recent change of -$11.27 million (-5.11%) on September 1, 2024.
- Over the past year, DRMA TTM SGA has dropped by -$235.76 million (-5935.34%).
- DRMA TTM SGA is now -725.45% below its all-time high of -$28.08 million.
Performance
DRMA TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
DRMA Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1.3% | -24.0% | -5935.3% |
| 3 y3 years | +153.8% | -7.7% | -6375.3% |
| 5 y5 years | +115.0% | -7.7% | -6375.3% |
DRMA Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -9.7% | at low | -48.6% | +0.2% | -76.3% | at low |
| 5 y | 5-year | -9.7% | +153.8% | -48.6% | +118.6% | -725.5% | at low |
| alltime | all time | -9.7% | +153.8% | -48.6% | +118.6% | -725.5% | at low |
Dermata Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $824.30 K(-5.8%) | $4.39 M(-1.9%) |
| Jun 2024 | - | $874.60 K(-45.4%) | $4.47 M(-0.4%) |
| Mar 2024 | - | $1.60 M(+47.8%) | $4.49 M(+13.0%) |
| Dec 2023 | $3.97 M(-1.3%) | $1.08 M(+19.3%) | $3.97 M(+7.1%) |
| Sep 2023 | - | $909.00 K(+1.7%) | $3.71 M(+0.4%) |
| Jun 2023 | - | $893.50 K(-17.6%) | $3.69 M(-5.7%) |
| Mar 2023 | - | $1.08 M(+31.9%) | $3.92 M(-2.6%) |
| Dec 2022 | $4.02 M | $822.30 K(-7.9%) | $4.02 M(-13.3%) |
| Sep 2022 | - | $892.80 K(-20.1%) | $4.64 M(-0.4%) |
| Jun 2022 | - | $1.12 M(-6.1%) | $4.66 M(+16.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $1.19 M(-17.4%) | $4.01 M(-8.9%) |
| Dec 2021 | $4.40 M(+181.0%) | $1.44 M(+57.9%) | $4.40 M(+31.9%) |
| Sep 2021 | - | $912.50 K(+97.2%) | $3.33 M(+17.4%) |
| Jun 2021 | - | $462.80 K(-70.7%) | $2.84 M(+3.0%) |
| Mar 2021 | - | $1.58 M(+319.3%) | $2.76 M(+76.3%) |
| Dec 2020 | $1.56 M(-15.3%) | $377.10 K(-10.1%) | $1.56 M(+31.7%) |
| Sep 2020 | - | $419.60 K(+10.2%) | $1.19 M(+54.6%) |
| Jun 2020 | - | $380.80 K(-1.7%) | $768.30 K(+98.3%) |
| Mar 2020 | - | $387.50 K | $387.50 K |
| Dec 2019 | $1.85 M | - | - |
FAQ
- What is Dermata Therapeutics annual SGA?
- What is the all time high annual SGA for Dermata Therapeutics?
- What is Dermata Therapeutics annual SGA year-on-year change?
- What is Dermata Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Dermata Therapeutics?
- What is Dermata Therapeutics quarterly SGA year-on-year change?
- What is Dermata Therapeutics TTM SGA?
- What is the all time high TTM SGA for Dermata Therapeutics?
- What is Dermata Therapeutics TTM SGA year-on-year change?
What is Dermata Therapeutics annual SGA?
The current annual SGA of DRMA is $3.97 M
What is the all time high annual SGA for Dermata Therapeutics?
Dermata Therapeutics all-time high annual SGA is $4.40 M
What is Dermata Therapeutics annual SGA year-on-year change?
Over the past year, DRMA annual SGA has changed by -$51.30 K (-1.28%)
What is Dermata Therapeutics quarterly SGA?
The current quarterly SGA of DRMA is $824.30 K
What is the all time high quarterly SGA for Dermata Therapeutics?
Dermata Therapeutics all-time high quarterly SGA is $1.60 M
What is Dermata Therapeutics quarterly SGA year-on-year change?
Over the past year, DRMA quarterly SGA has changed by -$260.30 K (-24.00%)
What is Dermata Therapeutics TTM SGA?
The current TTM SGA of DRMA is -$231.79 M
What is the all time high TTM SGA for Dermata Therapeutics?
Dermata Therapeutics all-time high TTM SGA is -$28.08 M
What is Dermata Therapeutics TTM SGA year-on-year change?
Over the past year, DRMA TTM SGA has changed by -$235.76 M (-5935.34%)